Kleanthis G Xanthopoulos - Net Worth and Insider Trading
Kleanthis G Xanthopoulos Net Worth
The estimated net worth of Kleanthis G Xanthopoulos is at least $1,028 dollars as of 2024-11-10. Kleanthis G Xanthopoulos is the President and CEO of Regulus Therapeutics Inc and owns about 699 shares of Regulus Therapeutics Inc (RGLS) stock worth over $1,028. Kleanthis G Xanthopoulos is also the Director of Zosano Pharma Corp and owns about 31 shares of Zosano Pharma Corp (ZSANQ) stock worth over $0. Details can be seen in Kleanthis G Xanthopoulos's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kleanthis G Xanthopoulos has not made any transactions after 2016-08-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kleanthis G Xanthopoulos
Kleanthis G Xanthopoulos Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kleanthis G Xanthopoulos owns 4 companies in total, including Zosano Pharma Corp (ZSANQ) , Seelos Therapeutics Inc (SEEL) , and Regulus Therapeutics Inc (RGLS) among others .
Click here to see the complete history of Kleanthis G Xanthopoulos’s form 4 insider trades.
Insider Ownership Summary of Kleanthis G Xanthopoulos
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ZSANQ | Zosano Pharma Corp | 2020-06-25 | director |
| SEEL | Seelos Therapeutics Inc | 2014-01-02 | director |
| RGLS | Regulus Therapeutics Inc | 2015-04-21 | director & President & CEO |
 | | 2007-12-03 | President of Regulus |
Kleanthis G Xanthopoulos Latest Holdings Summary
Kleanthis G Xanthopoulos currently owns a total of 2 stocks. Among these stocks, Kleanthis G Xanthopoulos owns 699 shares of Regulus Therapeutics Inc (RGLS) as of April 21, 2015, with a value of $1,028 and a weighting of 100%. Kleanthis G Xanthopoulos also owns 31 shares of Zosano Pharma Corp (ZSANQ) as of August 19, 2016, with a value of $0 and a weighting of 0%.
Latest Holdings of Kleanthis G Xanthopoulos
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RGLS | Regulus Therapeutics Inc | 2015-04-21 | 699 | 1.47 | 1,028 |
| ZSANQ | Zosano Pharma Corp | 2016-08-19 | 31 | 0.00 | 0 |
Holding Weightings of Kleanthis G Xanthopoulos
Kleanthis G Xanthopoulos Form 4 Trading Tracker
According to the SEC Form 4 filings, Kleanthis G Xanthopoulos has made a total of 0 transactions in Regulus Therapeutics Inc (RGLS) over the past 5 years. The most-recent trade in Regulus Therapeutics Inc is the sale of 1,667 shares on April 21, 2015, which brought Kleanthis G Xanthopoulos around $3 Million.
According to the SEC Form 4 filings, Kleanthis G Xanthopoulos has made a total of 0 transactions in Zosano Pharma Corp (ZSANQ) over the past 5 years. The most-recent trade in Zosano Pharma Corp is the acquisition of 23 shares on August 19, 2016, which cost Kleanthis G Xanthopoulos around $21,014.
Insider Trading History of Kleanthis G Xanthopoulos
- 1
Kleanthis G Xanthopoulos Trading Performance
GuruFocus tracks the stock performance after each of Kleanthis G Xanthopoulos's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kleanthis G Xanthopoulos is -52.77%. GuruFocus also compares Kleanthis G Xanthopoulos's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kleanthis G Xanthopoulos within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kleanthis G Xanthopoulos's insider trading performs compared to the benchmark.
Performance of Kleanthis G Xanthopoulos
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -40 | | | | | |
| Relative Return to S&P 500(%) | -37.95 | | | | | |
Kleanthis G Xanthopoulos Ownership Network
Ownership Network List of Kleanthis G Xanthopoulos
Ownership Network Relation of Kleanthis G Xanthopoulos
Kleanthis G Xanthopoulos Owned Company Details
What does Zosano Pharma Corp do?
Who are the key executives at Zosano Pharma Corp?
Kleanthis G Xanthopoulos is the director of Zosano Pharma Corp. Other key executives at Zosano Pharma Corp include director & Chief Executive Officer Steven Lo , Chief Financial Officer Christine Matthews , and VP & Clinical Dev & Med Affairs Donald J Kellerman .
Zosano Pharma Corp (ZSANQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Zosano Pharma Corp (ZSANQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zosano Pharma Corp (ZSANQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Zosano Pharma Corp (ZSANQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zosano Pharma Corp Insider Transactions
Kleanthis G Xanthopoulos Mailing Address
Above is the net worth, insider trading, and ownership report for Kleanthis G Xanthopoulos. You might contact Kleanthis G Xanthopoulos via mailing address: 9050 Camino Santa Fe, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
